Shih-Yin (Sharon) Chen
Senior Director, Head of Neuropsychiatry Franchise, Global Value & Access at Biogen- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Greater Boston
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Biogen
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Senior Director, Head of Neuropsychiatry Franchise, Global Value & Access
-
Mar 2022 - Present
-
-
Senior Director, Head of Pipeline Payer & Evidence Strategy, Global Value & Access
-
Nov 2020 - Mar 2022
- Led a diverse team including in-house data analytic capabilities and early to late stage multi-portfolio market access, pricing and reimbursement, evidence generation and demonstration strategy - Global Value & Access Ophthalmology Gene Therapy Franchise Lead
-
-
Director, Head of Pipeline Payer & Evidence Strategy, Global Value & Access
-
Mar 2018 - Nov 2020
Led a team responsible for Global Value & Access across mid to late stage pipeline portfolio
-
-
Associate Director, HEOR, Value & Access
-
Jul 2015 - Mar 2018
-
-
Senior Manager, Health Economics and Outcomes Research
-
Dec 2013 - Jul 2015
-
-
-
Evidera
-
United States
-
Research Services
-
400 - 500 Employee
-
Research Scientist
-
Jul 2011 - Nov 2013
-
-
Senior Research Associate
-
Jul 2010 - Jun 2011
-
-
Research Associate III
-
Nov 2008 - Jun 2010
-
-
Community
You need to have a working account to view this content.
Click here to join now